Miami, FL
Joined May 2010
- Tweets340
- Following65
- Followers235
- Likes834
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
The 2026 Whistler DAVA Summit on Hematological Malignancies has come to a close. We extend our gratitude to all participants for their valuable insights, expertise, and engaging questions and answers. #DAVAWhistler
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Starting Now: Emerging CAR-T Therapies in T-cell Lymphomas
Moderated by: Dr. Stephen Schuster @PennMedicine
#DAVAWhistler
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Anti-CD19 CAR-T demonstrates a manageable safety profile with reversible TEAEs and reductions in disease activity across SLE, SSc, and IIM; 91.6% of patients remained off therapy up to ~18 months, supporting potential for immune reset. Dr. @abeitin @umiamimedicine #DAVAWhistler
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Our stem cell transplant and cellular therapy program has earned designation as a Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Core Center. At the same time, the program is expanding access to care with the opening of a new outpatient satellite at University of Miami Health System SoLé Mia. 🙌
Dr. Amer Beitinjaneh serves as Sylvester’s site PI for the NHLBI-funded BMT CTN Core Center grant. His national collaborations and long-standing work with the BMT CTN helped position Sylvester for this designation and ongoing @NIH network participation. Learn more: loom.ly/2qDC1m0
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
CONGRESS | @TheIACH #IACH2024 | PRESENTATION
Amer Beitinjaneh @abeitin @univmiami @SylvesterCancer discusses the management of patients with R/R mantle cell lymphoma.
They highlight the role of BTK inhibitors, CAR T-cell therapies, transplantation, and novel therapies in the R/R setting.
Follow our live feed for more updates: lymphomahub.com/medical-info…
#lymphoma #lymsm #MedicalCongress
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
If you are in the South Florida area, come check this dinner program out.
Thursday 9/5/24 5pm-9pm @ Sunrise, FL
@FLASCO_ORG
members.flasco.org/calendaro…
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
@RickLin_ @ASTCT #IDTwitter #CMV #immunotherapy #tcellrx #lymphoma @SylvesterCancer @abeitin @amjimenezmd
CMV reactivation is a common complication of CAR T-cell therapy and is associated with increased overall mortality. ow.ly/uOfi50SMvUY #immunobiologyandimmunotherapy #healthservicesandoutcomes
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Great speaking to @Blood_Cancers about our multi-center effort investigating outcomes of HSCT in Hepatosplenic T cell lymphoma @DholariaMD @sairah__ahmed @AlhajMoustafa @abeitin @DeepJagMD @DrAmbuj @MKD_BMT @MayoCancerCare
pubmed.ncbi.nlm.nih.gov/3843…
Last week, @hemant_murthy, of @MayoCancerCare, stopped by BCT to talk about his recent study on #HSCT outcomes in patients with hepatosplenic T-cell lymphoma.
➡️ Watch here! buff.ly/3zBLnNT
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
He did the same with insulin. Relentless pressure to help patients. All 3 major insulin manufacturers cut their prices this year.
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Be a part of the symphony of lifesavers that helps patients get the blood stem cell transplants they need. #JoinTheSymphony with us, @MichelleObama, @BarackObama, @JonBatiste, @suleikajaouad, @MattHeineman, & @nmdp_org by learning how you can help 👉 bit.ly/3N4HyVg
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Congrats to @SylvesterCancer and Dr. Green and wishing them great success in expanding access and outcomes for cell therapy patients in South Florida and beyond. #bmtsm – at San Francisco, CA
We’re thrilled to welcome Damian Green, pioneering #immunotherapy & #MultipleMyeloma researcher and physician, as our new chief of Transplantation & Cellular Therapy and assistant director of Translational Research. Welcome to the team, Dr. Green! 🙌 loom.ly/rZ-xztw
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Last night, at @SylvesterCancer “Miami Nights” event, we announced Dr Damian Green is joining us as Chief of BMT & Cell Therapy Division. Together, we will expand immunotherapy in Miami! #mmsm @IMFmyeloma @theMMRF #ash23 @DrSDNimer
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Celebrating our #SylvesterStars! 🙌 In the spirit of recognizing #excellence, the Sylvester Stars Employee Recognition Breakfast was a success. 🎉 We look back on this event with #gratitude and thank our stars for their #dedication and tireless #commitment to our #mission. 🧡
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Record attendance for the @SylvesterCancer 2023 Design and Management of #Cancer #ClinicalTrials Course, and growing by the second! 🙌🏼🙌🏼🙌🏼 Everyone is tuned in to hear @LutzkyJose & @AlexiaIasonos review #phase1 trial design and statistics #SylvesterCTC2023
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
“Being Division Director is like being in charge of a cemetery. There’s a lot of people under you, but nobody’s listening!” - John DiPersio @DiPersioLab – at Iowa City, IA
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
We are heading to Jordan for our first meeting in November! #bmtsm #tcellRx
@ASamerAlHomsi1 @MKD_BMT @usamagergis @SherifFarag_BMT @abeitin @DrM_AbuZaid @MunaQayed @RabiHannaMD @NChokr @Razan_Mohty @jean_yared @DrMonzrAlMalki
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
PTCy, Abatacept and Short Course Tacrolimus, a feasible combination for acute GVHD prevention following haploidentical PB transplantations.
‘CAST regimen’
ashpublications.org/bloodadv…
